Zurcher Kantonalbank (Zurich Cantonalbank) Krystal Biotech, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 4,614 shares of KRYS stock, worth $878,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,614

Previous 4,614 -0.0%

Holding current value

$878,505

Previous $839,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$174.7 - $213.66 $26,729 - $32,689	153 Added 3.43%	4,614 $839,000
Q2 2024 Jul 29, 2024	BUY	$153.12 - $183.64 $25,877 - $31,035	169 Added 3.94%	4,461 $819,000
Q1 2024 Apr 25, 2024	SELL	$108.01 - $179.35 $18,685 - $31,027	-173 Reduced 3.87%	4,292 $763,000
Q4 2023 Jan 30, 2024	SELL	$96.0 - $128.29 $2,112 - $2,822	-22 Reduced 0.49%	4,465 $553,000
Q3 2023 Oct 25, 2023	BUY	$108.51 - $130.22 $49,046 - $58,859	452 Added 11.2%	4,487 $520,000
Q2 2023 Aug 07, 2023	BUY	$78.48 - $130.32 $101,867 - $169,155	1,298 Added 47.42%	4,035 $473,000
Q1 2023 May 08, 2023	SELL	$72.39 - $84.27 $37,642 - $43,820	-520 Reduced 15.97%	2,737 $219,000
Q4 2022 Feb 01, 2023	SELL	$63.14 - $79.9 $52,532 - $66,476	-832 Reduced 20.35%	3,257 $258,000
Q2 2022 Aug 09, 2022	SELL	$48.93 - $73.47 $1,761 - $2,644	-36 Reduced 0.87%	4,089 $268,000
Q1 2022 Apr 21, 2022	SELL	$51.99 - $72.11 $22,355 - $31,007	-430 Reduced 9.44%	4,125 $274,000
Q4 2021 Feb 01, 2022	BUY	$39.81 - $88.24 $143,435 - $317,928	3,603 Added 378.47%	4,555 $319,000
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $572 - $789	11 Added 1.17%	952 $50,000
Q2 2021 Jul 30, 2021	BUY	$62.14 - $81.82 $2,423 - $3,190	39 Added 4.32%	941 $64,000
Q1 2021 May 03, 2021	BUY	$59.42 - $85.46 $53,596 - $77,084	902 New	902 $69,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Krystal Biotech, Inc. Transaction History